Exosomes as Emerging Non-Invasive Biomarkers of Cervical Cancer: A Systematic Review and Meta-Analysis
Cancers · 10.12.2025 · 17 (24) · 3945
DOI: 10.3390/cancers17243945 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 10.12.2025. Verfasst von Fernanda Santos und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Gynaecology Department, University of Coimbra, 3004-504 Coimbra, Portugal. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Cervical cancer remains a significant global health burden, underscoring the imperative for refined diagnostic and prognostic methodologies. This study aimed to evaluate the potential of extracellular vesicles (EVs) as non-invasive biomarkers for cervical cancer, focusing on diagnosis and prognosis.
Methods
We conducted a systematic review and meta-analysis in accordance with PRISMA guidelines to assess the diagnostic and prognostic accuracy of EV-based biomarkers. We searched PubMed, EMBASE, and Web of Science for relevant studies. Twelve articles met the inclusion criteria: eight related to diagnostic accuracy, three to prognosis, and one to both outcomes. Six studies met the criteria for meta-analysis. We used a random-effects model to synthesise diagnostic data, while prognostic data were synthesised narratively.
Results
The meta-analysis yielded a pooled area under the receiver operating characteristic curve (AUC) of 0.87 (95% CI 0.80–0.92) for EVs in the diagnosis of cervical cancer, indicating high accuracy. The evaluated diagnostic biomarkers were primarily non-coding RNAs. For prognosis, data heterogeneity precluded quantitative synthesis; however, individual studies identified diverse EV-associated molecules correlated with recurrence and survival. GRADE assessment indicated a high risk of bias and heterogeneity across studies.
Conclusions
Extracellular vesicles demonstrate robust promise as diagnostic biomarkers for cervical cancer; however, their prognostic utility remains inconclusive due to methodological and clinical heterogeneity. Future research must prioritise the standardisation of isolation protocols and the execution of large-scale, prospective studies to validate EV biomarkers for clinical application. Systematic Review Registration: PROSPERO, identifier: CRD420251014411.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, Gynaecology Department, University of Coimbra, 3004-504 Coimbra, Portugal.
- Coimbra Academic and Clinical Centre, 3000-075 Coimbra, Portugal.
- Gynaecology Department, ULS-Coimbra Hospital and University Centre of Coimbra, 3004-561 Coimbra, Portugal.
- Laboratory of Biostatistics and Medical Informatics (LBIM), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.
- Centre for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3004-504 Coimbra, Portugal.
- Blood and Transfusion Medicine Department at ULS Coimbra, ULS-Coimbra Hospital and University Centre of Coimbra, 3004-561 Coimbra, Portugal.
ORCID-Profile: Francisco A Caramelo, Luis P Almeida, Margarida Figueiredo-Dias
Zitieren
APA
Santos, F., Caramelo, F. A., Tomaz, J. M. P., Santana, M. M., Nobre, R. J., Almeida, L. P., & Figueiredo-Dias, M. (2025). Exosomes as Emerging Non-Invasive Biomarkers of Cervical Cancer: A Systematic Review and Meta-Analysis. Cancers, 17(24), 3945. https://doi.org/10.3390/cancers17243945
Vancouver
Santos F, Caramelo FA, Tomaz JMP, Santana MM, Nobre RJ, Almeida LP, et al. Exosomes as Emerging Non-Invasive Biomarkers of Cervical Cancer: A Systematic Review and Meta-Analysis. Cancers. 2025;17(24):3945. doi:10.3390/cancers17243945
BibTeX
@article{Santos2025,
author = {Santos, Fernanda and Caramelo, Francisco A and Tomaz, Jorge M P and Santana, Magda M and Nobre, Rui J and Almeida, Luis P and Figueiredo-Dias, Margarida},
title = {Exosomes as Emerging Non-Invasive Biomarkers of Cervical Cancer: A Systematic Review and Meta-Analysis},
journal = {Cancers},
year = {2025},
volume = {17},
number = {24},
pages = {3945},
doi = {10.3390/cancers17243945}
}
EUVIMED